A good night's sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
The new Center for Recovery and Wellbeing and a Pathways to Recovery website seeks to break down barriers for those fighting addiction.
Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.
The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...
US federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The US Food and Drug ...
A doctor with NYU says this new pill is not addictive. A mother who lost her son from opioid addiction hopes for the best but wants to see if this new pill will truly be a safe alternative.